Evaluation of the efficacy of the Italian guidelines on COPD: A cluster randomized trial

Monaldi Archives for Chest Disease

Volumn 59, Issue 3, 2003, Pages 199-206

  Tinelli, Carmine ^a   Rezzani, C ^b   Biino, G ^b   Marinoni, A ^b   Rossi, A ^a   Volpini, E ^a   Pistoria, A ^a   Termini, R ^c   Grassi, M ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Boehringer Ingelheim Italia SpA   (Italy)

Author keywords

Chronic obstructive pulmonary disease; Family practice; Guidelines; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CLUSTER ANALYSIS; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG USE; FEMALE; GENERAL PRACTICE; HOSPITAL ADMISSION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OUTCOMES RESEARCH; OUTPATIENT DEPARTMENT; PRACTICE GUIDELINE; PROBABILITY; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING; FOLLOW UP; GENERAL PRACTITIONER; HOSPITAL MANAGEMENT; OUTPATIENT;

EID: 1642485028     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gulsvik A. The global burden and impact of chronic obstructive pulmonary disease worldwide. Monaldi Arch Chest Dis, 2001; 56: 261-264.
2. ISTAT. Annuario Statistico Italiano 1999. Istituto di Statistica Nazionale, Roma, 1999.
3. Gugiatti A, Bertolini F. Elementi per la definizione dei costi sanitari delle broncopneumopatie cronico-ostruttive. Mecosan, 1992; 2: 18-25.
4. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). A consensus statement of the European Respiratory Society (ERS). Eur Respir J 1995; 8: 1398-1420.
5. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 1995; 152: S78-121.
6. Broncopneumopatie Croniche Ostruttive - Stato del-l'Arte. Rassegna di Patologia dell'Apparato Respiratorio 1998; 13 (5).
7. Mahler DA. How should health-related quality of life be assessed in patients with COPD? Chest 2000 Feb; 117 (2 Suppl): 54S-7S.
8. Mahler DA, Jones PW. Measurement of dyspnea and quality of life in advanced lung disease. Clin Chest Med 1977; 18: 457-469.
9. Feinstein AR. An additional basic science for clinical medicine: IV. The development of clinimetrics. Ann Intern Med 1983; 99: 843-848.
10. Apolone G, Mosconi P. The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 1998; 51: 1025-1036.
11. Jans MP, Schellevis FG, van Hensbergen W, Dukkers van Emden T, van Eijk JT. Management of asthma and COPD patients: Feasibility of the application of guidelines in general practice. Int J Qual Health Care, 1998; 10 (1): 27-34.
12. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol 2000 Jul; 53 (7): 755-761.
13. ISTAT Condizioni di salute e ricorso ai servizi sanitari. Indagine multiscopo sulle famiglie. Anno 1997. Roma 1999 (Informazioni n. 12).
14. Bosisio M, Parma E, Apolone G, Bertolini G. La valutazione dello stato di salute in pazienti ambulatoriali con bronchite cronica. Uno studio di esito nella medicina generale. Ricerca e Clinica 1996; 12: 55-62.
15. Alonso J, Prieto L, Ferrer M, Vilagut G, Broquetas JM, Roca J, Batlle JS, Anto JM. Are results of the SF-36 Health Survey and the Notthingam Health profile similar? A comparison in COPD Patients. Study Group. J Clin Epidemiol 1998; 51 (11): 1087-1094.
16. Alonso J, Prieto L, Ferrer M, Vilagut G, Broquetas JM, Roca J, Batlle JS, Anto JM. Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with chronic obstructive pulmonary disease. Quality of Life in COPD Study Group. J Clin Epidemiol 1998; 51 (11): 1087-1094.
17. Ware JE, Sherbourne CD. The MOS 36-item Short-form Health Survey (SF-36) I. Conceptual framework and item selection. Med Care 1992; 30 (11): 473-483.
18. Keller SD, Ware JE Jr, Bentler PM, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Kaasa S, Leplege A, Sullivan M, Gandek B. Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998 Nov; 51 (11): 1179-1188.
19. Keller SD, Ware JE Jr, Gandek B, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Fukuhara S, Kaasa S, Leplege A, Sanson-Fisher RW, Sullivan M, Wood-Dauphinee S. Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998 Nov; 51 (11): 933-944.
20. Gandek B, Ware JE Jr, Aaronson NK, Alonso J, Apolone G, Bjorner J, Brazier J, Bullinger M, Fukuhara S, Kaasa S, Leplege A, Sullivan M. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998 Nov; 51 (11): 1149-1158.
21. SM Kerry and JM Bland. Statistics notes: The intracluster correlation coefficient in cluster randomisation. BMJ 1998; 316: 1455-1460.
22. Crowder MJ, Hand DJ. Analysis of Repeated Measures (Monographs on Statistics and Applied Probability, 41). Chapman & Hall, 1990.
23. Long JS. Regression Modeles for Categorical and Limited Dependent Variables. Sage: Thousand Oaks, CA, 1997.